Table 2 Summary of clinicopathological characteristics of the endometrial cancer group
From: CD44, TGM2 and EpCAM as novel plasma markers in endometrial cancer diagnosis
| FIGO stage | Grade | Invasion | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IA | IB | II | IIIA | IIIB | IIIC1 | IIIC2 | IV | 1 | 2 | 3 | < 0.5 | > = 0.5 | |
| EC (n) | 24 | 12 | 0 | 0 | 3 | 6 | 0 | 0 | 23 | 18 | 4 | 26 | 19 |